Third, we show that the level of PD-L1 expression correlates with CD8+ T-cell infiltration at the tumour margins, suggesting that an active immune resistance mechanism is present, which may potentially be overcome by PD1/PD-L1 therapy in a subset of glioblastomas with PD-L1 expression at the tumour margin. The gene discussed is CD8A; the disease is neoplasm.